Skip to main content
Caplight Logo









DeepLife

DeepLife

Private
ParisHealthcare & Life Scienceshttps://www.deeplife.co/

Last Round

Series A

Dec 10, 2024

Total Funding Raised

$15.87M

Company Overview

DeepLife is a biotechnology company that develops an AI-powered SaaS platform using digital twins of cells to accelerate drug discovery, target identification, and cell engineering for pharmaceutical and biotech partners.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

cellular digital twinAI drug discoveryin-silico simulationtarget identificationdrug repositioningtechbiogenerative AIcomputational biologycausal AIdigital biologygenerative biologybiotech SaaSmulti-omics dataautoimmune diseaseneurodegenerative disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepLife Comparables

Compare DeepLife with similar companies based on industry and business-model similarity.

DeepLife comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cytocast
84%
Turbine
80%
VeriSIM Life
78%

DeepLife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 10, 2024
SeedAug 3, 2022

Key People

Founding team and executive leadership

Jonathan Baptista

Co-founder & CEO

Founding Team

DeepLife Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2025

    Monthly visitors grew 303% MoM, reaching 1.9K.

  • Nov 15, 2025

    Grew 19% QoQ, from 31 to 37 employees.

DeepLife Filings

Explore SEC and related filing metadata, where available.

DeepLife filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DeepLife's valuation, stock price, and market status.

Is DeepLife a public or private company?

DeepLife is a private company.

What is the current stock price of DeepLife?

DeepLife is a private company with no public stock price. No recent secondary market data is available.

How much is DeepLife worth (valuation)?

Valuation information for DeepLife is not publicly available.

Can I buy DeepLife stock?

DeepLife shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DeepLife's last funding round?

Funding round information for DeepLife is not publicly available.

Who are the main investors in DeepLife?

Investor information for DeepLife is not publicly disclosed.

Will DeepLife IPO soon?

No public IPO plans have been announced for DeepLife.

How can I track DeepLife secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepLife's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range23
Year Founded2019
Last FundingDec 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?